Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Delayed Cerebral Ischemia Following Subarachnoid Hemorrhage
NCT03028298Phase 1Unknown
- Sponsor
- University of Mississippi Medical Center
- Start
- Dec 2016
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of sildenafil in cerebral vasospasm (2 arms), sponsored by University of Mississippi Medical Center. Primary endpoints: Change from baseline in mean arterial blood pressure at 2 hours and Area under the plasma concentration versus time curve of sildenafil. Status: unknown.
02
Drugs
sildenafil
03
Conditions
cerebral vasospasm
Beyond the preview
Go deeper on NCT03028298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03028298.